HLA-A2.1-restricted education and cytolytic activity of CD8 super(+) T lymphocytes from beta 2 microglobulin ( beta 2m) HLA-A2.1 monochain transgenic H-2D super(b) beta 2m double knockout mice
Three different HLA-A2.1 monochains were engineered in which either the human or mouse beta 2-microglobulin ( beta 2m) is covalently linked to the NH sub(2) terminus of the heavy chain by a 15-amino acid long peptide: HHH, entirely human, HHD, with the mouse H-2D super(b) alpha 3, transmembrane, and...
Gespeichert in:
Veröffentlicht in: | The Journal of experimental medicine 1997-06, Vol.185 (12), p.2043-2051 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Three different HLA-A2.1 monochains were engineered in which either the human or mouse beta 2-microglobulin ( beta 2m) is covalently linked to the NH sub(2) terminus of the heavy chain by a 15-amino acid long peptide: HHH, entirely human, HHD, with the mouse H-2D super(b) alpha 3, transmembrane, and cytoplasmic domains, and MHD, homologous to HHD but linked to the mouse beta 2m super(b). The cell surface expression and immunological capacities of the three monochains were compared with transfected cells, and the selected HHD construct was introduced by transgenesis in H-2D super(b-/-) beta 2m super(-/-) double knockout mice. Expression of this monochain restores a sizable peripheral CD8 super(+) T cell repertoire essentially educated on the transgenic human molecule. Consequently, infected HHD, H-2D super(b-/-) beta 2m super(-/-) mice generate only HLA-A2.1-restricted CD8 super(+) CTL responses against influenza A and vaccinia viruses. Interestingly, the CTL response to influenza A virus is mostly, if not exclusively, directed to the 58-66 matrix peptide which is the HLA-A2.1-restricted immunodominant epitope in humans. Such mice might constitute a versatile animal model for the study of HLA-A2.1-restricted CTL responses of vaccine interest. |
---|---|
ISSN: | 0022-1007 |